SCHEMBL14718502

SCHEMBL14718502

CN(C(=O)O)c1ccc(-c2cc(F)ccc2N)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KEAP1 Q14145 1/20 0.42
LTB4R2 Q9NPC1 3/20 0.39
MAP4K4 O95819 1/20 0.38
RELA Q04206 6/20 0.38
HDAC2 Q92769 2/20 0.36
HDAC3 O15379 1/20 0.36
HDAC1 Q13547 1/20 0.36
RORC P51449 1/20 0.36
TUBB4A P04350 1/20 0.34
TUBB P07437 1/20 0.34
TUBA3C P0DPH7 1/20 0.34
TUBA1B P68363 1/20 0.34
TUBA4A P68366 1/20 0.34
TUBB4B P68371 1/20 0.34
TUBB3 Q13509 1/20 0.34
TUBB2A Q13885 1/20 0.34
TUBB8 Q3ZCM7 1/20 0.34
TUBA3E Q6PEY2 1/20 0.34
TUBA1A Q71U36 1/20 0.34
TUBA1C Q9BQE3 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14718754 0.78 ATM (0.43) ALDH1A1
SCHEMBL20520835 0.78 KEAP1 (0.50) KEAP1HDAC2HDAC3HDAC1ALDH1A1
SCHEMBL2095324 0.77 GAA (0.44) KMT2A
SCHEMBL6557724 0.75 ALDH1A1 (0.52) KEAP1MAP4K4RELAALDH1A1KMT2A
SCHEMBL21586818 0.74 HDAC1 (0.42) KEAP1HDAC2HDAC3HDAC1CA12
SCHEMBL2589767 0.74 LTB4R2 (0.43) KEAP1LTB4R2HDAC2HDAC3HDAC1
Acetic Acid SCHEMBL30206663 0.73 KEAP1 (0.57) KEAP1HDAC2HDAC3HDAC1CA1
SCHEMBL11788282 0.73 HDAC1 (0.44) HDAC1ALDH1A1KDM4EKMT2A
SCHEMBL1178024 0.73 SMN1; SMN2 (0.43) RORCTUBB4ATUBBTUBA3CTUBA1B
SCHEMBL15269267 0.72 ACHE (0.46) ALDH1A1KDM4EKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2563358-A1 INHIBITORS OF PHOSPHOINOSITIDE DEPENDENT KINASE 1 (PDK1) Merck Sharp & Dohme Corp. (US) 2013-03-06 EP disclosed
US-20130053382-A1 Inhibitors of Phosphoinositide Dependent Kinase 1 (PDK1) PALIWAL SUNIL (US) 2013-02-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130053382-A1 Inhibitors of Phosphoinositide Dependent Kinase 1 (PDK1) PDK1, PDPK1, PDK3 KEAP1 1040/4885LTB4R2 4726/4885MAP4K4 155/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.